Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario F Feldman

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|February 8, 2018
Expanding the molecular weaponry of bacterial speciesJuvenal Lopez, Mario F Feldman
EMBO Reports|June 9, 2020
The future of conferences, today: Are virtual conferences a viable supplement to "live" conferences?Dor Salomon, Mario F Feldman
Methods in Enzymology|September 23, 2017
Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine DevelopmentEzequiel Valguarnera, Mario F Feldman
Glycobiology|September 28, 2010
Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteriaIsabelle Hug, Mario F Feldman
Glycobiology|April 17, 2019
Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coliChristian M Harding, Mario F Feldman
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2024
Screening for Genes Involved in Outer Membrane Vesicle Biogenesis in Bacteroides thetaiotaomicronEvan J Pardue, Mario F Feldman
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2015
Glyco-engineering O-Antigen-Based Vaccines and Diagnostics in E. coliNicolas F Vozza, Mario F Feldman
FEMS Microbiology Letters|March 7, 2003
The multitalented type III chaperones: all you can do with 15 kDaMario F Feldman, Guy R Cornelis
Glycobiology|November 25, 2010
Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirementsMaria V Ielmini, Mario F Feldman
Expert Opinion on Therapeutic Targets|January 24, 2003
The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?Simone Müller, Mario F Feldman, Guy R Cornelis
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|February 8, 2018
Expanding the molecular weaponry of bacterial speciesJuvenal Lopez, Mario F Feldman
EMBO Reports|June 9, 2020
The future of conferences, today: Are virtual conferences a viable supplement to "live" conferences?Dor Salomon, Mario F Feldman
Methods in Enzymology|September 23, 2017
Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine DevelopmentEzequiel Valguarnera, Mario F Feldman
Glycobiology|September 28, 2010
Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteriaIsabelle Hug, Mario F Feldman
Glycobiology|April 17, 2019
Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coliChristian M Harding, Mario F Feldman
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2024
Screening for Genes Involved in Outer Membrane Vesicle Biogenesis in Bacteroides thetaiotaomicronEvan J Pardue, Mario F Feldman
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2015
Glyco-engineering O-Antigen-Based Vaccines and Diagnostics in E. coliNicolas F Vozza, Mario F Feldman
FEMS Microbiology Letters|March 7, 2003
The multitalented type III chaperones: all you can do with 15 kDaMario F Feldman, Guy R Cornelis
Glycobiology|November 25, 2010
Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirementsMaria V Ielmini, Mario F Feldman
Expert Opinion on Therapeutic Targets|January 24, 2003
The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?Simone Müller, Mario F Feldman, Guy R Cornelis
Pageof 12